NOVARTIS PHARMACEUTICALS CORPORATION - RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS

PIID: 36C24426F0063

Signed Date: Dec 19, 2025Effective Date: Jan 1, 2026End Date: Closes in 203 days

Award $

$2.0M

Vendor

NOVARTIS PHARMACEUTICALS CORPORATION

NAICS

325412

Signed Date

Dec 19, 2025

Key Details

Dollars Obligated

$2.0M

Base & All Options

$2.0M

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

LEBANON, PA, 170429407, CD-PA-09

Description

RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS

Context & Analysis

On Dec 19, 2025, Department of Veterans Affairs obligated $1,980,570.88 to NOVARTIS PHARMACEUTICALS CORPORATION for radiopharmaceuticals-lutathera and pluvicto injections. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in LEBANON, PA. The contract is scheduled through Dec 31, 2026 — approximately 7 months remaining.